Germanylachen
BAD HOMBURG, Germany and LACHEN, Switzerland -
Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation(R) Technology to develop a HESylated recombinant protein.
